Nova Trial Stream

 

IHH Healthcare shows growth

Malaysia and Singapore based Asia-focussed IHH Healthcare’s 2021 results show dynamic growth. Turkish groups are being impacted by the depreciation of the lira, but while revenue from domestic patients in Turkish subsidiary Acibadem shrank between 2017 and 2020, it grew in 2021, up 16.9% year-on-year.

Lim and others eye up IVIRMA

Singapore billionaire Peter Lim is said to be in talks to buy IVIRMA, the Euro-American fertility player where big private equity is expected to bid high. HBI understands other bidders may include KKR, Carlyle and Cinven.

$3bn Amil for sale in Brazil

UnitedHealthcare owned Amil is for sale in Brazil. Reports in Brazil say the $3bn plus valued insurance and hospital businesses run by Amil are likely to be split and sold to at least two separate buyers. HBI speaks to a Brazilian source to find out more.

Intermedica and Hapvida’s get green light for merger

Two giants of Brazilian healthcare, listed HMOs Hapvida Participacoes e Investimentos SA and Grupo Notre Dame Intermedica Participacoes (GNDI), have received approval to merge from the country's antitrust authority CADE. The merger will create the country's biggest provider of health insurance policies, with around a 20% share of the for-profit market by number of users, and a 10% share of revenue.

IHH to “vigorously defend” $6.5bn lawsuit

Listed Malaysian hospital group IHH Healthcare says it will 'vigorously defend' a $6.5bn suit by US fund Emqore relating to the issuance of shares by IHH-owned Indian hospital group Fortis.

Mediclinic Middle East acquires homecare group

Mediclinic Middle East is acquiring Ayadi Home Healthcare (Ayadi), which provides home healthcare services to patients in Abu Dhabi and Al Ain. The acquisition is a further step towards becoming an integrated healthcare provider.

Find Us